[1]Buck,JasonR.;Saleh,Sam;ImamUddin,Md.;Manning,H.Charles[TetrahedronLetters,2012,vol.53,#32,p.4161-4165]
[1]Buck,JasonR.;Saleh,Sam;ImamUddin,Md.;Manning,H.Charles[TetrahedronLetters,2012,vol.53,#32,p.4161-4165]
[1]Buck,JasonR.;Saleh,Sam;ImamUddin,Md.;Manning,H.Charles[TetrahedronLetters,2012,vol.53,#32,p.4161-4165]
[1]Kuttruff,ChristianA.;Haile,Margit;Kraml,Johannes;Tautermann,ChristoferS.[ChemMedChem,2018,vol.13,#10,p.983-987]
Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: Conformation-specific effects of Raf kinase inhibitors.
Journal: Journal of medicinal chemistry 20120913
Title: Distinct requirement for an intact dimer interface in wild-type, V600E and kinase-dead B-Raf signalling.
Journal: The EMBO journal 20120530
Title: Role and therapeutic potential of PI3K-mTOR signaling in de novo resistance to BRAF inhibition.
Journal: Pigment cell & melanoma research 20120301
Title: Small molecule inhibitors of BRAF in clinical trials.
Journal: Bioorganic & medicinal chemistry letters 20120115
Title: Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20111115
Title: Comprehensive analysis of kinase inhibitor selectivity.
Journal: Nature biotechnology 20111030
Title: B-Raf associates with and activates the NHE1 isoform of the Na+/H+ exchanger.
Journal: The Journal of biological chemistry 20110415
Title: Targeting BRAFV600E with PLX4720 displays potent antimigratory and anti-invasive activity in preclinical models of human thyroid cancer.
Journal: The oncologist 20110301
Title: MEK-independent survival of B-RAFV600E melanoma cells selected for resistance to apoptosis induced by the RAF inhibitor PLX4720.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20110215
Title: Hyperactivation of MEK-ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells.
Journal: Oncogene 20110120
Title: Selective BRAFV600E inhibitor PLX4720, requires TRAIL assistance to overcome oncogenic PIK3CA resistance.
Journal: PloS one 20110101
Title: A switch in RND3-RHOA signaling is critical for melanoma cell invasion following mutant-BRAF inhibition.
Journal: Molecular cancer 20110101
Title: A simple protocol for using a LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time.
Journal: PloS one 20110101
Title: Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry.
Journal: Chemistry & biology 20101124
Title: Apoptosis of human melanoma cells induced by inhibition of B-RAFV600E involves preferential splicing of bimS.
Journal: Cell death & disease 20100901
Title: Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy.
Journal: British journal of cancer 20100608
Title: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
Journal: Nature 20100318
Title: RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.
Journal: Nature 20100318
Title: Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells.
Journal: The Journal of clinical endocrinology and metabolism 20100101
Title: Effectively targeting BRAF in melanoma: a formidable challenge.
Journal: Pigment cell & melanoma research 20080801
Title: Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity.
Journal: Proceedings of the National Academy of Sciences of the United States of America 20080226
Title: In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research 20030101
Title: Tsai J, et al. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity. Proc Natl Acad Sci U S A, 2008, 105(8), 3041-3046.
Title: Paraiso KH, et al. PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression. Cancer Res, 2011, 71(7), 2750-2760.
Title: Nucera C, et al. B-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression. Proc Natl Acad Sci U S A, 2010, 107(23), 10649-10654.
Title: Rizzolio S, et al. Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies. J Clin Invest. 2018 Aug 31;128(9):3976-3990.
